Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8737)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2013 (publication date) through Apr 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tarantino G, Finelli C. Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease. World J Gastroenterol 2013; 19(40): 6735-6743 [PMID: 24187449 DOI: 10.3748/wjg.v19.i40.6735] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i40/6735.htm |
| Number | Citing Articles |
| 1 |
Rui-Xu Yang, Jian-Gao Fan. Metabolic Steatotic Liver Disease. 2024; : 123 doi: 10.1016/B978-0-323-99649-5.00004-2
|
| 2 |
Margarita Pizarro, Nancy Solís, Pablo Quintero, Francisco Barrera, Daniel Cabrera, Pamela Rojas‐de Santiago, Juan P. Arab, Oslando Padilla, Juan C. Roa, Han Moshage, Alexander Wree, Eugenia Inzaugarat, Ariel E. Feldstein, Carlos E. Fardella, Rene Baudrand, Arnoldo Riquelme, Marco Arrese. Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis. Liver International 2015; 35(9): 2129 doi: 10.1111/liv.12794
|
| 3 |
Sermin Kesebir. Metabolic syndrome and childhood trauma: Also comorbidity and complication in mood disorder. World Journal of Clinical Cases 2014; 2(8): 332-337 doi: 10.12998/wjcc.v2.i8.332
|
| 4 |
Hwan Ma, Guo-Yan Sui, Jeong-Su Park, Feng Wang, Yuanqiang Ma, Dong-Su Shin, Nodir Rustamov, Jun Sung Jang, Soo Im Chang, Jin Lee, Yoon Seok Roh. Blockade of 11β-hydroxysteroid dehydrogenase type 1 ameliorates metabolic dysfunction-associated steatotic liver disease and fibrosis. Heliyon 2024; 10(20): e39534 doi: 10.1016/j.heliyon.2024.e39534
|
| 5 |
Patrik Nasr, Cecilia Jönsson, Mattias Ekstedt, Stergios Kechagias. Non-metabolic causes of steatotic liver disease. Metabolism and Target Organ Damage 2023; 3(4) doi: 10.20517/mtod.2023.20
|
| 6 |
Emmanuel O. Mensah, Emmanuel K. Danyo, Richard V. Asase. Exploring the effect of different diet types on ageing and age-related diseases. Nutrition 2025; 129: 112596 doi: 10.1016/j.nut.2024.112596
|
| 7 |
Komal Sodhi, Krithika Srikanthan, Perrine Goguet-Rubio, Alexandra Nichols, Amrita Mallick, Athar Nawab, Rebecca Martin, Preeya T. Shah, Muhammad Chaudhry, Saroj Sigdel, Mehiar El-Hamdani, Jiang Liu, Zijian Xie, Nader G. Abraham, Joseph I. Shapiro. RETRACTED ARTICLE: pNaKtide Attenuates Steatohepatitis and Atherosclerosis by Blocking Na/K-ATPase/ROS Amplification in C57Bl6 and ApoE Knockout Mice Fed a Western Diet. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00306-5
|
| 8 |
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
|
| 9 |
M. Georgoulis, M. D. Kontogianni, A. Margariti, D. Tiniakos, E. Fragopoulou, R. Zafiropoulou, G. Papatheodoridis. Associations between dietary intake and the presence of the metabolic syndrome in patients with non‐alcoholic fatty liver disease. Journal of Human Nutrition and Dietetics 2015; 28(4): 409 doi: 10.1111/jhn.12323
|
| 10 |
Dongwei Xu, Min Xu, Seogsong Jeong, Yihan Qian, Hailong Wu, Qiang Xia, Xiaoni Kong. The Role of Nrf2 in Liver Disease: Novel Molecular Mechanisms and Therapeutic Approaches. Frontiers in Pharmacology 2019; 9 doi: 10.3389/fphar.2018.01428
|
| 11 |
Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu, Anca Trifan, Branka Filipović. Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6678142
|
| 12 |
Adriana Corona-Pérez, Mauricio Díaz-Muñoz, Estela Cuevas-Romero, Dalia Luna-Moreno, Héctor Valente-Godínez, Olivia Vázquez-Martínez, Margarita Martínez-Gómez, Jorge Rodríguez-Antolín, Leticia Nicolás-Toledo. Interactive effects of chronic stress and a high-sucrose diet on nonalcoholic fatty liver in young adult male rats. Stress 2017; 20(6): 608 doi: 10.1080/10253890.2017.1381840
|
| 13 |
Nikolaos Nikolaou, Laura L. Gathercole, Lea Marchand, Sara Althari, Niall J. Dempster, Charlotte J. Green, Martijn van de Bunt, Catriona McNeil, Anastasia Arvaniti, Beverly A. Hughes, Bruno Sgromo, Richard S. Gillies, Hanns-Ulrich Marschall, Trevor M. Penning, John Ryan, Wiebke Arlt, Leanne Hodson, Jeremy W. Tomlinson. AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease. Metabolism 2019; 99: 67 doi: 10.1016/j.metabol.2019.153947
|
| 14 |
E. Sabath, A. Báez‐Ruiz, R. M. Buijs. Non‐alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization. Obesity Reviews 2015; 16(10): 871 doi: 10.1111/obr.12308
|
| 15 |
Mónica B. Jiménez-Castro, Elsa Negrete-Sánchez, Araní Casillas-Ramírez, Jose Gulfo, Ana I. Álvarez-Mercado, María Eugenia Cornide-Petronio, Jordi Gracia-Sancho, Juan Rodés, Carmen Peralta. The effect of cortisol in rat steatotic and non-steatotic liver transplantation from brain-dead donors. Clinical Science 2017; 131(8): 733 doi: 10.1042/CS20160676
|
| 16 |
Lian Gong, Guo-En Wang, Qing-Yu Ma, Wen-Zhi Hao, Min-Hua Xian, Yan-Ping Wu, Hiroshi Kurihara, Rong-Rong He, Jia-Xu Chen. Novel insights into the effect of Xiaoyao san on corticosterone-induced hepatic steatosis: inhibition of glucocorticoid receptor/perilipin-2 signaling pathway. Acupuncture and Herbal Medicine 2022; 2(1): 49 doi: 10.1097/HM9.0000000000000011
|
| 17 |
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
|
| 18 |
Chesinta Voma, Andrew Barfell, Colleen Croniger, Andrea Romani. Reduced cellular Mg2+ content enhances hexose 6-phosphate dehydrogenase activity and expression in HepG2 and HL-60 cells. Archives of Biochemistry and Biophysics 2014; 548: 11 doi: 10.1016/j.abb.2014.02.016
|
| 19 |
Timothy Wang, Wei Yang, Sidika Karakas, Souvik Sarkar. NASH in Nondiabetic Endocrine Disorders. Metabolic Syndrome and Related Disorders 2018; 16(7): 315 doi: 10.1089/met.2018.0044
|
| 20 |
W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett, Alan J. Garber, Daniel L. Hurley, Ania M. Jastreboff, Karl Nadolsky, Rachel Pessah-Pollack, Raymond Plodkowski. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity. Endocrine Practice 2016; 22: 1 doi: 10.4158/EP161365.GL
|
| 21 |
Minmeng Zhao, Ya Xing, Lidong Liu, Xiang Fan, Long Liu, Tuoyu Geng, Daoqing Gong. GC-TOF-MS-Based Metabolomics Analyses of Liver and Intestinal Contents in the Overfed vs. Normally-Fed Geese. Animals 2020; 10(12): 2375 doi: 10.3390/ani10122375
|
| 22 |
Peter Dietrich, Claus Hellerbrand. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology 2014; 28(4): 637 doi: 10.1016/j.bpg.2014.07.008
|
| 23 |
Meritxell Perramón, Wladimiro Jiménez. Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases. International Journal of Molecular Sciences 2022; 23(13): 6897 doi: 10.3390/ijms23136897
|
| 24 |
Melanie Schranz, Maria Grazia Lucà, Lorenzo D’Antiga, Stefano Fagiuoli. Pediatric Hepatology and Liver Transplantation. 2019; : 361 doi: 10.1007/978-3-319-96400-3_22
|
| 25 |
Yosuke Sasaki, Takuyuki Katabami, Shiko Asai, Hisashi Fukuda, Yasushi Tanaka. In the overnight dexamethasone suppression test, 1.0 mg loading is superior to 0.5 mg loading for diagnosing subclinical adrenal Cushing’s syndrome based on plasma dexamethasone levels determined using liquid chromatography-tandem mass spectrometry. Endocrine Journal 2017; 64(9): 833 doi: 10.1507/endocrj.EJ17-0083
|
| 26 |
Fafeng Cheng, Chongyang Ma, Xueqian Wang, Changming Zhai, Guoli Wang, Xiaolin Xu, Jie Mu, Changxiang Li, Zisong Wang, Xiaoyu Zhang, Wenchao Yue, Xin Du, Yajun Lian, Wenxiang Zhu, Xiangjun Yin, Zhen Wei, Wenjie Song, Qingguo Wang. Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-017-1707-2
|
| 27 |
Chen Ding, Yaxin Tang, Wenqiang Zhu, Piaopiao Huang, Pingan Lian, Juanli Ran, Xiansheng Huang. Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis. Acta Diabetologica 2022; 59(4): 519 doi: 10.1007/s00592-021-01830-7
|
| 28 |
Poredoš P, Schernthaner GH, Blinc A, Mikhailidis DP, Jensterle M, Anagnostis P, Antignani PL, Bajuk Studen K, Šabović M, Ježovnik MK. Endocrine Disorders and Peripheral Arterial Disease – A Series of Reviews
Cushing Syndrome-Cortisol Excess. Current Vascular Pharmacology 2024; 22(4): 236 doi: 10.2174/0115701611272145231106053914
|
| 29 |
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
|
| 30 |
Faith I. Buckley, Orla Mahony, Cynthia R. L. Webster. Adrenal function in cats with cholestatic liver disease. Journal of Veterinary Diagnostic Investigation 2017; 29(1): 14 doi: 10.1177/1040638716671978
|
| 31 |
Sanjay Kalra, Saptarshi Bhattacharya, Pawan Rawal. Hepatocrinology. Medical Sciences 2021; 9(2): 39 doi: 10.3390/medsci9020039
|
| 32 |
A. Baranova, D. Maltseva, A. Tonevitsky. Adipose may actively delay progression of NAFLD by releasing tumor‐suppressing, anti‐fibrotic miR‐122 into circulation. Obesity Reviews 2019; 20(1): 108 doi: 10.1111/obr.12765
|
| 33 |
Meng Yang, Feng Ma, Min Guan. Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Metabolites 2021; 11(5): 320 doi: 10.3390/metabo11050320
|
| 34 |
Mingshu Li, Fuchang Deng, Li Dong, Xiaona Wang, Haiyan Jiang, Siyu Yao, Yuanyuan Chen, Lian Duan, Huamao Du, Guangqiu Qin, Song Tang. Phase-dependent hepatotoxicity of Aluminum oxide nanoparticles mediated through the intestinal microbiota. Environment International 2025; 198: 109398 doi: 10.1016/j.envint.2025.109398
|
| 35 |
Anaïs Vallet-Pichard, Lucia Parlati, Stanislas Pol. Épidémiologie de la stéato-hépatite non alcoolique. Étendue du problème et son impact sur la santé publique. La Presse Médicale 2019; 48(12): 1459 doi: 10.1016/j.lpm.2019.08.008
|
| 36 |
Qing Zhang, Yueli Zhu, Wanjiang Yu, Zhipeng Xu, Zhenzhen Zhao, Shousheng Liu, Yongning Xin, Kuirong Lv. Diagnostic accuracy assessment of molecular prediction model for the risk of NAFLD based on MRI-PDFF diagnosed Chinese Han population. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01675-y
|
| 37 |
Ying-Jen Chen, Jiann-Torng Chen, Ming-Cheng Tai, Chang-Min Liang, Yuan-Yuei Chen, Tung-Wei Kao, Wen-Hui Fang, Wei-Liang Chen. Examining the associations among intraocular pressure, hepatic steatosis, and anthropometric parameters. Medicine 2019; 98(43): e17598 doi: 10.1097/MD.0000000000017598
|
| 38 |
|
| 39 |
Ravindra Shukla, Asish Kumar Basu, Biplab Mandal, Pradip Mukhopadhyay, Animesh Maity, Satyam Chakraborty, Praveen Kumar Devrabhai. 11β Hydroxysteroid dehydrogenase – 1 activity in type 2 diabetes mellitus: a comparative study. BMC Endocrine Disorders 2019; 19(1) doi: 10.1186/s12902-019-0344-9
|
| 40 |
Carmine Finelli. Molecular Mechanisms and Mediators of Hepatotoxicity Resulting from an Excess of Lipids and Non-Alcoholic Fatty Liver Disease. Gastrointestinal Disorders 2023; 5(2): 243 doi: 10.3390/gidisord5020020
|
| 41 |
Süleyman GÜNAY, Zehra Betül PAKÖZ, Haydar ADANIR. Evaluation of C-reactive protein levels in the differentiation of non-alcoholic steatohepatitis and simple liver steatosis. Akdeniz Medical Journal 2022; : 202 doi: 10.53394/akd.976570
|
| 42 |
Silvio Buscemi, Davide Corleo, Carola Buscemi, Carla Giordano. Does iris(in) bring bad news or good news?. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 2018; 23(4): 431 doi: 10.1007/s40519-017-0431-8
|
| 43 |
Stergios A. Polyzos, Giovanni Targher. Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease. Current Obesity Reports 2024; 13(2): 242 doi: 10.1007/s13679-024-00556-1
|
| 44 |
Mauro Cataldi, Vincenzo Citro, Chiara Resnati, Federica Manco, Giovanni Tarantino. New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants. Advances in Therapy 2021; 38(5): 2094 doi: 10.1007/s12325-021-01669-y
|
| 45 |
S. K. Ternovoy, G. A. Shiryaev, D. V. Ustyuzhanin, D. T. Abdurakhmanov. EVALUATION OF LIPID CONTENT IN PATIENTS WITH LIVER STEATOSIS AND STEATOHEPATITIS USING PROTON MR-SPECTROSCOPY. Medical Visualization 2018; (4): 50 doi: 10.24835/1607-0763-2018-4-50-58
|
| 46 |
Mauro Zamboni, Andrea P Rossi, Francesco Fantin, Simona L Budui, Elena Zoico, Giulia A Zamboni, Gloria Mazzali. Predictors of Ectopic Fat in Humans. Current Obesity Reports 2014; 3(4): 404 doi: 10.1007/s13679-014-0126-7
|
| 47 |
Carla Scaroni, Marialuisa Zilio, Michelangelo Foti, Marco Boscaro. Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management. Endocrine Reviews 2017; 38(3): 189 doi: 10.1210/er.2016-1105
|
| 48 |
Xin Huang, Tong Li, Shi‐hui Yang, Kong‐di Zhu, Lian‐shun Wang, Yu‐lan Dong, Jia‐qiang Huang. Hepatocyte‐specific Selenoi deficiency predisposes mice to hepatic steatosis and obesity. The FASEB Journal 2024; 38(11) doi: 10.1096/fj.202400575RR
|
| 49 |
Jieun Lee, Kijung Yoon, Seungho Ryu, Yoosoo Chang, Hyoung-Ryoul Kim, Christina Chan. High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men. PLOS ONE 2017; 12(2): e0172666 doi: 10.1371/journal.pone.0172666
|
| 50 |
Kaela Ellis, Michelle Brandt-Sarif, Julee Sunny, Shifra Koyfman. General Hepatitis. Pediatrics In Review 2022; 43(9): 493 doi: 10.1542/pir.2021-005279
|
| 51 |
Yuezhu Zhang, Shuyue Wang, Tianyang Zhao, Liwei Yang, Shuangyu Guo, Yanbin Shi, Xueting Zhang, Liting Zhou, Lin Ye. Mono-2-ethylhexyl phthalate (MEHP) promoted lipid accumulation via JAK2/STAT5 and aggravated oxidative stress in BRL-3A cells. Ecotoxicology and Environmental Safety 2019; 184: 109611 doi: 10.1016/j.ecoenv.2019.109611
|
| 52 |
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
|
| 53 |
María Eugenia Cornide‐Petronio, Esther Bujaldon, Mariana Mendes‐Braz, Cindy G. Avalos de León, Mónica B. Jiménez‐Castro, Ana I. Álvarez‐Mercado, Jordi Gracia‐Sancho, Juan Rodés, Carmen Peralta. The impact of cortisol in steatotic and non‐steatotic liver surgery. Journal of Cellular and Molecular Medicine 2017; 21(10): 2344 doi: 10.1111/jcmm.13156
|
| 54 |
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; : 731 doi: 10.1016/B978-1-63067-036-8.00028-7
|
| 55 |
Amedeo Lonardo, Juan Pablo Arab, Marco Arrese. Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in Therapy 2021; 38(5): 2130 doi: 10.1007/s12325-021-01690-1
|
| 56 |
Dongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Annals of Hepatology 2023; 28(4): 100726 doi: 10.1016/j.aohep.2022.100726
|
| 57 |
Dahae Lee, Tuy An Trinh, Myoung-Sook Shin, Ki Sung Kang. Recent Advancements in Microbial Diversity. 2022; : 209 doi: 10.1016/B978-0-12-822368-0.00009-8
|
| 58 |
Harsimran Singh, Shabir Sidhu, Kanwaljit Chopra, M.U. Khan. Hepatoprotective effect oftrans-Chalcone on experimentally induced hepatic injury in rats: inhibition of hepatic inflammation and fibrosis. Canadian Journal of Physiology and Pharmacology 2016; 94(8): 879 doi: 10.1139/cjpp-2016-0071
|
| 59 |
Tolulope Eniola Omolekulo, Emmanuel Damilare Areola, Olufunto Olayinka Badmus, Olugbenga Samuel Michael, Inkyeom Kim, Lawrence Aderemi Olatunji. Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen–progestin. Canadian Journal of Physiology and Pharmacology 2018; 96(11): 1092 doi: 10.1139/cjpp-2018-0231
|
| 60 |
Zili Zhang, Zhen Yao, Yifan Chen, Lei Qian, Shuoyi Jiang, Jingyi Zhou, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng. Lipophagy and liver disease: New perspectives to better understanding and therapy. Biomedicine & Pharmacotherapy 2018; 97: 339 doi: 10.1016/j.biopha.2017.07.168
|
| 61 |
Thandar Oo, Noboru Sasaki, Yoshinori Ikenaka, Takahiro Ichise, Noriyuki Nagata, Nozomu Yokoyama, Kazuyoshi Sasaoka, Keitaro Morishita, Kensuke Nakamura, Mitsuyoshi Takiguchi. Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study. Frontiers in Veterinary Science 2022; 9 doi: 10.3389/fvets.2022.1014792
|
| 62 |
Giovanni Tarantino, Carmine Finelli. Handbook of Lipids in Human Function. 2016; : 85 doi: 10.1016/B978-1-63067-036-8.00004-4
|